Article
The role of local ablative therapy in oligometastatic non-small-cell lung cancer: hype or hope.
Future oncology (London, England) - 1 Dec 2016
Bansal Pranshu, Rusthoven Chad, Boumber Yanis, Gan Gregory N
Abstract excerpt
In recent years, the emergence of the oligometastatic state has called into question whether patients found to have a limited or low metastatic tumor burden may benefit from locally ablative therapy (LAT). In the past two decades, stereotactic body radiation therapy has been increasingly used to safely deliver LAT and provide high local control in nonoperable non-small-cell lung cancer patients. Mostly...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.